| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |